NCT04423614

Brief Summary

In light of the corona virus pandemic (COVID-19), there is critical need to conserve scarce mechanical ventilation (MV) resources. This study evaluates an intervention in non-infected cardiac patients as a means to assist with minimizing MV and ICU length of stay (LOS). Pre-op inspiratory muscle training (IMT) has been shown to decrease pulmonary complications, MV dependence, and ICU LOS following thoracic surgery. The investigators aim to determine the mechanism of remodeling in diaphragms of adults who undergo pre-op IMT.

Trial Health

15
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Timeline
Completed

Started Dec 2021

Shorter than P25 for not_applicable

Status
withdrawn

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 2, 2020

Completed
7 days until next milestone

First Posted

Study publicly available on registry

June 9, 2020

Completed
1.5 years until next milestone

Study Start

First participant enrolled

December 1, 2021

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 5, 2022

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

January 5, 2022

Completed
Last Updated

January 21, 2022

Status Verified

January 1, 2022

Enrollment Period

1 month

First QC Date

June 2, 2020

Last Update Submit

January 10, 2022

Conditions

Keywords

Mechanical ventilationInspiratory muscle trainingDifficulty weaning from mechanical ventilation

Outcome Measures

Primary Outcomes (2)

  • Maximal inspiratory pressure

    Maximal inspiratory pressure will be quantified in cm of water pressure.

    Post breathing exercise sessions (up to 4 weeks)

  • Muscle fiber cross-sectional area and fiber type proportion.

    Histology will be used to determine fiber type and cross-sectional area using primary antibodies for laminin and type-specific myosin heavy chain, followed by a triple immunofluorescence-conjugated secondary antibody labeling technique.

    Intra-operatively

Secondary Outcomes (8)

  • Peak expiratory flow

    Post breathing exercise sessions (up to 4 weeks)

  • Time to extubation

    Up to discharge from ICU

  • Length of ICU stay

    Up to 1 month

  • Length of hospital stay

    Up to 1 month

  • Neuromuscular junction morphology

    Intra-operatively

  • +3 more secondary outcomes

Study Arms (2)

Inspiratory Muscle Training (IMT)

EXPERIMENTAL

Pre-operative inspiratory muscle training

Other: Inspiratory Muscle Training

Relaxation Breathing (RLX)

EXPERIMENTAL

Relaxation breathing exercises

Other: Relaxation Breathing

Interventions

Inspiratory muscle training exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.

Inspiratory Muscle Training (IMT)

Relaxation breathing exercises, performed 5 times a week for 2-4 weeks prior to cardiac surgery.

Relaxation Breathing (RLX)

Eligibility Criteria

Age55 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Cardiac surgery candidate
  • Ability to complete pre-operative breathing exercises

You may not qualify if:

  • Surgery is scheduled in less than 2 weeks
  • New York Heart Association Class III or IV Cardiac Disease
  • History of hemiparesis
  • History of spinal cord injury
  • History of progressive neuromuscular disease that may interfere with the ability to complete study interventions
  • Previous cardiothoracic surgery within the last 12 weeks
  • History of pneumonectomy
  • History of lung surgery
  • History of skeletal pathology (e.g. scoliosis) that may interfere with chest wall movements
  • Routine usage of muscle relaxants, immunosuppressants, or corticosteroid medications within the past 30 days
  • Forced expiratory volume 1 less than 40% of age-predicted value
  • Presence of active malignancy
  • Presence of any organ dysfunction that may limit ability to participate in seated respiratory exercises

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Officials

  • Barbara Smith, PhD, PT

    University of Florida

    PRINCIPAL INVESTIGATOR
  • Thomas Beaver, MD, MPH

    University of Florida

    PRINCIPAL INVESTIGATOR
0

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
PREVENTION
Intervention Model
PARALLEL
Model Details: Subjects will be randomized into one of two arms. In Arm 1, subjects will perform pre-operative inspiratory muscle training. In Arm 2, subjects will perform pre-operative relaxation breathing. A diaphragm biopsy will be taken during surgery for both arms and the tissue will be compared. In addition, a biopsy of the pectoralis major will be obtained from each subject and serve as a non-exercised control which will compared to the subject's diaphragm muscle biopsy (which participated in the intervention).
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 2, 2020

First Posted

June 9, 2020

Study Start

December 1, 2021

Primary Completion

January 5, 2022

Study Completion

January 5, 2022

Last Updated

January 21, 2022

Record last verified: 2022-01